Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 19, 2015 CD
Six back issues from 2015 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 19 No. 1 January/February 2015 Volume 19, Number 1
Vol. 19 No. 2 March/April 2015 Volume 19, Number 2
Vol. 19 No. 3 May/June 2015 Volume 19, Number 3
Vol. 19 No. 4 July/August 2015 Volume 19, Number 4
Vol. 19 No. 5 September/October 2015 Volume 19, Number 5
Vol. 19 No. 6 November/December 2015 Volume 19, Number 6

Volume 19, 2015 CD ARTICLES

Volume19, 2015 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: 2014 in Review Vol. 19 No. 1 4
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Vol. 19 No. 1 6
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists Vol. 19 No. 1 14
Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding Vol. 19 No. 1 18
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Vol. 19 No. 1 30
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Vol. 19 No. 1 38
Quality Control Analytical Methods: Refractive Index Vol. 19 No. 1 43
Basics of Sterile Compounding: Aseptic Processing Vol. 19 No. 1 49
Basics of Compounding: The Revised "Not to Compound List" Vol. 19 No. 1 57
Calculations Vol. 19 No. 1 59
Atenolol 25-, 50-, or 100-mg Capsules Vol. 19 No. 1 60
Azathioprine 50-mg Capsules Vol. 19 No. 1 61
Cisplatin 1-mg/mL Injection Vol. 19 No. 1 62
Daunorubicin 5-mg/mL Injection Vol. 19 No. 1 63
Erythromycin 50-mg/mL Injection Vol. 19 No. 1 64
Hydralazine Hydrochloride 20-mg/mL Injection Vol. 19 No. 1 65
Hydroxychloroquine Sulfate 200-mg Capsules Vol. 19 No. 1 66
Lidocaine Hydrochloride 4% Topical Solution Vol. 19 No. 1 67
Mupirocin 2% Ointment Vol. 19 No. 1 68
Phentolamine Mesylate 5-mg/mL Injection Vol. 19 No. 1 69
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Vol. 19 No. 1 70
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Vol. 19 No. 1 73
Stability of Suspensions: Theoretical and Practical Considerations before Compounding Vol. 19 No. 1 78
PostScription: Pharmacists Advancing Toward Provider Status Vol. 19 No. 1 86
PreScription: Some of the Best Sermons are Lived, not Preached! Vol. 19 No. 2 92
New England Compounding Center Indictment Vol. 19 No. 2 94
Standing Together Fixing the Drug Quality and Security Act Vol. 19 No. 2 104
Standarized Compounding: The Importance of Doing it the Same Way Every Time Vol. 19 No. 2 109
Bedside Manner: Not Just for Doctors Anymore Vol. 19 No. 2 115
Quality Assurance and Quality Control, Part 1 Vol. 19 No. 2 121
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Vol. 19 No. 2 127
Calculations Vol. 19 No. 2 140
Acne Scrub Vol. 19 No. 2 142
Aminohippurate Sodium 200-mg/mL Injection Vol. 19 No. 2 143
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Vol. 19 No. 2 144
Heparin 335-United/Gram Gel-Cream Vol. 19 No. 2 145
L-Cysteine Hydrochloride 50-mg/mL Injection Vol. 19 No. 2 146
Morrhuate Sodium 5% Injection Vol. 19 No. 2 147
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Vol. 19 No. 2 148
Pancuronium Bromide 1-mg/mL Injection Vol. 19 No. 2 149
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 2 150
Trypan Blue 0.06% Ophthalmic Solution Vol. 19 No. 2 151
Transdermal Delivery of Nisoldipine: Refinement of Vehicles Vol. 19 No. 2 152
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Vol. 19 No. 2 161
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Vol. 19 No. 2 167
PostScription: What's Your Patient Care Story? Vol. 19 No. 2 174
PreScription: 2015 Student Pharmacist Compounding Competition Vol. 19 No. 3 180
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Vol. 19 No. 3 182
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Vol. 19 No. 3 195
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Vol. 19 No. 3 205
IACP Says: "Fix DQSA" Vol. 19 No. 3 212
Quality Assurance and Quality Control, Part 2 Vol. 19 No. 3 215
Basics of Compounding: Compounding with Silicones Vol. 19 No. 3 223
Basics of Sterile Compounding: Contamination Control Vol. 19 No. 3 232
Calculations Vol. 19 No. 3 240
Atropine Sulfate 1% Ophthalmic Solution Vol. 19 No. 3 242
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Vol. 19 No. 3 243
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Vol. 19 No. 3 244
Phenazopyridine Hydrochloride 200-mg Capsules Vol. 19 No. 3 245
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 3 246
Scopolamine Hydrobromide -.4-mg/mL Injection Vol. 19 No. 3 247
Stability of Metronidazole Suspensions Vol. 19 No. 3 248
Protocol of Blood Serum Eye Drops Vol. 19 No. 3 252
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Vol. 19 No. 3 261
PreScription: Potpourri of Opinions…From Many Vol. 19 No. 4 266
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Vol. 19 No. 4 268
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Vol. 19 No. 3 268
PostScription: Opportunities to Change the Pharmacy Landscape Vol. 19 No. 3 271
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Vol. 19 No. 4 280
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Vol. 19 No. 4 289
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Vol. 19 No. 4 295
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Vol. 19 No. 4 303
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units Vol. 19 No. 4 307
Basics of Compounding: The "Negative" List Vol. 19 No. 4 311
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Vol. 19 No. 4 315
Calculations Vol. 19 No. 4 322
Ammonium Molybdate 25-mcg/mL Injection Vol. 19 No. 4 324
Balsam Peru, Castor Oil, and Trypsin Ointment Vol. 19 No. 4 325
Benzonatate 100-mg Capsules Vol. 19 No. 4 326
Chloroquine Phosphate 250-mg Capsules Vol. 19 No. 4 327
Cytarabine 50-mg/mL Injection Vol. 19 No. 4 328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Vol. 19 No. 4 329
Oxytocin 10-units/mL Injection Vol. 19 No. 4 330
Phytonadione 2-mg/mL Injection Vol. 19 No. 4 331
Proparacaine Hydrochloride 0.5% Ophthalmic Solution Vol. 19 No. 4 332
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Vol. 19 No. 4 333
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Vol. 19 No. 4 334
Stability of Prednisone in Oral Mix Suspending Vehicle Vol. 19 No. 4 337
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals Vol. 19 No. 4 340
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Vol. 19 No. 4 344
PostScription: APhA2015: You Spoke, We Listened, and What a Success! Vol. 19 No. 4 348
PreScription: Failure or Success? Vol. 19 No. 5 354
Novel Approaches to Topical Psoriasis Therapy Vol. 19 No. 5 357
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Vol. 19 No. 5 367
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Vol. 19 No. 5 375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Vol. 19 No. 5 377
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Vol. 19 No. 5 383
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Vol. 19 No. 5 389
Sterile Filtration Vol. 19 No. 5 393
Calculations Vol. 19 No. 5 402
Aminocaproic Acid 250-mg/mL Oral Solution Vol. 19 No. 5 404
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Vol. 19 No. 5 405
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Vol. 19 No. 5 406
Nimodipine 3-mg/mL Oral Solution Vol. 19 No. 5 407
Ofloxacin 0.3% Otic Solution Vol. 19 No. 5 408
Povidone Iodine 10% Cold Sore Paint Vol. 19 No. 5 409
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Vol. 19 No. 5 410
Vehicle for Oral Solution (National Formulary 26) Vol. 19 No. 5 411
Vehicle for Oral Solution, Sugar Free (National Formulary 26) Vol. 19 No. 5 412
Vehicle for Oral Suspension (National Formulary 26) Vol. 19 No. 5 413
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Vol. 19 No. 5 414
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Vol. 19 No. 5 420
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Vol. 19 No. 5 428
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Vol. 19 No. 5 432
PostScription: Progress Report: Provider Status Continues to Gain Strength! Vol. 19 No. 5 437
PreScription: The Documented Past and the Exciting Future Vol. 19 No. 6 442
Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding" Vol. 19 No. 6 444
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Vol. 19 No. 6 449
Applying Quality of Design Concepts to Pharmacy Compounding Vol. 19 No. 6 453
Root Cause Analysis, Part 1: Nonsterile Compounding Vol. 19 No. 6 465
Basic Principles of Lyophilization, Part 1 Vol. 19 No. 6 471
Mixing in a Compounding Pharmacy in the 21st Century Vol. 19 No. 6 479
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Vol. 19 No. 6 487
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Vol. 19 No. 6 491
Calculations Vol. 19 No. 6 502
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Vol. 19 No. 6 504
Cefepime Hydrochloride 100-mg/mL Injection Vol. 19 No. 6 505
Cefotaxime 100-mg/mL Injection Vol. 19 No. 6 506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Vol. 19 No. 6 507
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Vol. 19 No. 6 508
Estradiol Valerate 40-mg/mL in Oil Injection Vol. 19 No. 6 509
Levetiracetam 100-mg/mL Injection (Concentrate) Vol. 19 No. 6 510
Memantine Hydrochloride Capsules Vol. 19 No. 6 511
Mupirocin 2% Nasal Ointment Vol. 19 No. 6 512
Propranolol Hydrochloride Capsules Vol. 19 No. 6 513
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Vol. 19 No. 6 514
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Vol. 19 No. 6 521
PostScription: Pharmacy Fellowship Program: Building a Stronger Profession Vol. 19 No. 6 525